Abstract

Background: Breast cancer, one of the most prevalent cancers in women, negatively affects women's survival and health-related quality of life. Women with breast cancer need to discuss treatment options with their doctors thoroughly in order to make optimal treatment decisions. Objective: The aims of this study were to apply Rasch analysis to examine the construct validity and person reliability of the 9-item Shared Decision Making Questionnaire (SDM-Q-9) in women with breast cancer. Methods: The construct validity of the SDM-Q-9 was confirmed when the items fit the Rasch model's assumptions of unidimensionality: (1) infit and outfit mean square (MNSQ) ranged from 0.6 to 1.4; (2) the unexplained variance of the first dimension of the principle component analysis (PCA) was < 20%. Person reliability was calculated. Results: A total of 212 participants were recruited in this study. Item 1 did not fit the model's assumptions and was deleted. The unidimensionality of the remaining 8 items (SDM-Q-8) was supported with good item fit (infit and outfit MNSQ ranging from 0.6 to 1.3) and very low unexplained variance of the first dimension (5.3%) of the PCA. The person reliability of the SDM-8 was 0.90. Conclusions: The SDM-Q-8 was unidimensional and had good person reliability in women with breast cancer. Implications for practice: The SDM-Q-8 has shown its potential for assessing the level of perceived involvement in shared decision-making in women with breast cancer for both research and clinical purposes.
Original languageEnglish
Pages221-222
Number of pages2
DOIs
Publication statusPublished - 2018
EventThe 25th Cochrane Colloquium - Edinburgh International Conference Centre, Edinburgh, United Kingdom
Duration: Sept 16 2018Sept 18 2018
Conference number: 25th

Conference

ConferenceThe 25th Cochrane Colloquium
Country/TerritoryUnited Kingdom
City Edinburgh
Period9/16/189/18/18

Fingerprint

Dive into the research topics of 'Rasch analysis of the 9-item Shared Decision Making Questionnaire for women with breast cancer'. Together they form a unique fingerprint.

Cite this